These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24588789)

  • 1. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.
    Bath PM; Houlton A; Woodhouse L; Sprigg N; Wardlaw J; Pocock S;
    Int J Stroke; 2014 Apr; 9(3):372-4. PubMed ID: 24588789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics of the 4011 patients recruited into the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial.
    ENOS Investigators
    Int J Stroke; 2014 Aug; 9(6):711-20. PubMed ID: 25043647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.
    ENOS Trial Investigators
    Lancet; 2015 Feb; 385(9968):617-628. PubMed ID: 25465108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
    RIGHT-2 Investigators
    Lancet; 2019 Mar; 393(10175):1009-1020. PubMed ID: 30738649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).
    Appleton JP; Scutt P; Dixon M; Howard H; Haywood L; Havard D; Hepburn T; England T; Sprigg N; Woodhouse LJ; Wardlaw JM; Montgomery AA; Pocock S; Bath PM;
    Int J Stroke; 2019 Feb; 14(2):191-206. PubMed ID: 28762896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial.
    Krishnan K; Scutt P; Woodhouse L; Adami A; Becker JL; Cala LA; Casado AM; Chen C; Dineen RA; Gommans J; Koumellis P; Christensen H; Collins R; Czlonkowska A; Lees KR; Ntaios G; Ozturk S; Phillips SJ; Sprigg N; Szatmari S; Wardlaw JM; Bath PM;
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1017-1026. PubMed ID: 26853137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical analysis plan for the 'Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)'.
    Scutt P; Appleton JP; Dixon M; Woodhouse LJ; Sprigg N; Wardlaw JM; Montgomery AA; Pocock S; Bath PM
    Eur Stroke J; 2018 Jun; 3(2):193-196. PubMed ID: 31008350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis.
    Appleton JP; Woodhouse LJ; Belcher A; Bereczki D; Berge E; Caso V; Chang HM; Christensen HK; Collins R; Gommans J; Laska AC; Ntaios G; Ozturk S; Sare GM; Szatmari S; Wang Y; Wardlaw JM; Sprigg N; Bath PM
    Stroke Vasc Neurol; 2019 Mar; 4(1):28-35. PubMed ID: 31105976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial.
    Bath PM; Scutt P; Appleton JP; Dixon M; Woodhouse LJ; Wardlaw JM; Sprigg N
    Int J Stroke; 2019 Apr; 14(3):298-305. PubMed ID: 30475165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial.
    Woodhouse L; Scutt P; Krishnan K; Berge E; Gommans J; Ntaios G; Wardlaw J; Sprigg N; Bath PM;
    Stroke; 2015 Nov; 46(11):3194-201. PubMed ID: 26463698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis.
    Krishnan K; Scutt P; Woodhouse L; Adami A; Becker JL; Berge E; Cala LA; Casado AM; Caso V; Chen C; Christensen H; Collins R; Czlonkowska A; Dineen RA; Gommans J; Koumellis P; Lees KR; Ntaios G; Ozturk S; Phillips SJ; Pocock SJ; de Silva A; Sprigg N; Szatmari S; Wardlaw JM; Bath PM
    Stroke; 2016 Jan; 47(1):44-52. PubMed ID: 26645254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial.
    Bath PM; Robson K; Woodhouse LJ; Sprigg N; Dineen R; Pocock S;
    Int J Stroke; 2015 Apr; 10(3):449-51. PubMed ID: 25640807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
    van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
    Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of transdermal glyceryl trinitrate on 24 h ambulatory blood pressure in acute/subacute stroke.
    Geeganage CM; Bath AJ; Bath PM
    Int J Stroke; 2011 Aug; 6(4):290-4. PubMed ID: 21609410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122).
    ENOS Trial Investigators
    Int J Stroke; 2006 Nov; 1(4):245-9. PubMed ID: 18706028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial.
    Woodhouse LJ; Scutt P; Hamdy S; Smithard DG; Cohen DL; Roffe C; Bereczki D; Berge E; Bladin CF; Caso V; Christensen HK; Collins R; Czlonkowska A; de Silva A; Etribi A; Laska AC; Ntaios G; Ozturk S; Phillips SJ; Prasad K; Szatmari S; Sprigg N; Bath PM
    Transl Stroke Res; 2018 Apr; 9(2):120-129. PubMed ID: 28770403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke.
    Bath PM; Pathansali R; Iddenden R; Bath FJ
    Cerebrovasc Dis; 2001; 11(3):265-72. PubMed ID: 11306778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.
    Godolphin PJ; Montgomery AA; Woodhouse LJ; Bereczki D; Berge E; Collins R; Díez-Tejedor E; Gommans J; Lees KR; Ozturk S; Phillips S; Pocock S; Prasad K; Szatmari S; Wang Y; Bath PM; Sprigg N;
    PLoS One; 2018; 13(11):e0208142. PubMed ID: 30475912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is lowering blood pressure hazardous in patients with significant ipsilateral carotid stenosis and acute ischaemic stroke? Interim assessment in the 'Efficacy of Nitric Oxide in Stroke' trial.
    Sare GM; Gray LJ; Wardlaw J; Chen C; Bath PM;
    Blood Press Monit; 2009 Feb; 14(1):20-5. PubMed ID: 19106795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of glyceryl trinitrate: clinical applications in acute stroke.
    Appleton JP; Krishnan K; Bath PM
    Expert Opin Drug Deliv; 2020 Mar; 17(3):297-303. PubMed ID: 31973594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.